Is testing for ESBL production necessary? A pro/con debate_Enduring

This activity will impact the interprofessional healthcare team by education clinicians on this topic that is not well understood by the general healthcare population, and often extensively discussed/debated and managed by infectious diseases specialists. This session will highlight the importance of how to recognize an ESBL-producing organism, define generally accepted treatment options based on the type of infection, and present clinical scenarios where there is still controversy based on the available scientific evidence.

 

Additional Resources:

  • CLSI M100: CLSI eClipse Ultimate Access - Powered by Edaptive Technologies (edaptivedocs.net)
  • Tamma PD, Humphries RM. PRO: Testing for ESBL production is necessary for ceftriaxone-non-susceptible Enterobacterales: perfect should not be the enemy of progress. JAC Antimicrob Resist. 2021 May 7;3(2):dlab019. doi: 10.1093/jacamr/dlab019. PMID: 33987537; PMCID: PMC8103002.
  • Mathers AJ, Lewis JS 2nd. CON: Testing for ESBL production is unnecessary for ceftriaxone-resistant Enterobacterales. JAC Antimicrob Resist. 2021 May 7;3(2):dlab020. doi: 10.1093/jacamr/dlab020. PMID: 34223109; PMCID: PMC8210140.

Target Audience

Nurse
Nurse Practitioner
Pharmacist
Physician

Learning Objectives

Upon completion of this activity, participants should be able to:

  1. Discuss pros of testing for ESBL production in ceftriaxone-non-susceptible Enterobacterales
  2. Describe cons of testing for ESBL production in ceftriaxone-non-susceptible Enterobacterales
  3. Determine how microbiology laboratories and antimicrobial stewardship teams can collaborate to improve care of patients with multidrug-resistant infections
Course summary
Available credit: 
  • 1.00 ACPE Pharmacy
    The UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.
  • 1.00 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • 1.00 ANCC
    UPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
  • 1.00 Attendance
Course opens: 
01/13/2022
Course expires: 
12/31/2025

This activity will impact the interprofessional healthcare team by education clinicians on this topic that is not well understood by the general healthcare population, and often extensively discussed/debated and managed by infectious diseases specialists. This session will highlight the importance of how to recognize an ESBL-producing organism, define generally accepted treatment options based on the type of infection, and present clinical scenarios where there is still controversy based on the available scientific evidence.

Pittsburgh, PA
United States

Moderator:   Erin K. McCreary, PharmD, BCPS, BCIDP
Clinical Assistant Professor of Medicine, University of Pittsburgh
Division of Infectious Diseases, UPMC
Director of Stewardship Innovation, Infectious

Pranita D. Tamma, MD - Director, Pediatric Antimicrobial Stewardship Program, Associate Professor of Pediatrics, John Hopkins Medical

James (Jim) Lewis III, PharmD,  FIDSA - PGY2 Infectious Diseases Residency Program Coordinator, OHSU Hospital and Clinics Pharmacy Residency Program, Oregon Health & Science University.

No relationships with industry relevant to the content of this educational activity have been disclosed.


Authors disclosure of relevant financial relationships with any entity producing, marketing, re-selling, or distributing health care goods or services, used on, or consumed by, patients is listed above. No other planners, members of the planning committee, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.

In support of improving patient care, the University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The University of Pittsburgh designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing (CNE)
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours.

Pharmacy (CPE)
This knowledge-based activity provides 1.0 contact hours of continuing pharmacy education credit. 

Other Healthcare Professionals:
Other health care professionals will receive a certificate of attendance confirming the number of contact hours commensurate with the extent of participation in this activity.

Available Credit

  • 1.00 ACPE Pharmacy
    The UPMC Center for Continuing Education in the Health Sciences is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a Provider of continuing pharmacy education.
  • 1.00 AMA PRA Category 1 Credit™
    The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
  • 1.00 ANCC
    UPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
  • 1.00 Attendance
Please login or register to take this course.

Choose Register/Complete Course to complete the module.  

First time Users: If you have never completed training on this website, please select register in the upper right hand corner of the webpage.

Returning Users: If you have completed training on this website, please log in in the upper right hand corner of the webpage.